Viewing Study NCT05555732

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:44 PM
Ignite Modification Date: 2025-12-30 @ 7:51 AM
Study NCT ID: NCT05555732
Status: RECRUITING
Last Update Posted: 2025-09-11
First Post: 2022-09-22
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)
Sponsor: Daiichi Sankyo
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Non Small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Metastatic Non Small Cell Lung Cancer View
None Advanced Non Small Cell Lung Cancer View
None Datopotamab Deruxtecan (Dato-DXd) View
None Pembrolizumab View
None Pemetrexed View
None Tropion-Lung07 View